News

January 22, 2019January 22, 2019

Cognitive Behavioral Therapy Reduces COPD-related Anxiety and Hospital Visits, Study Shows

News

Cognitive behavioral therapy (CBT) intervention can alleviate anxiety in people with chronic obstructive pulmonary disease (COPD), and reduce long-term hospital costs, a study shows. The results were published in ... Read more

January 18, 2019January 18, 2019

Exosomes Released by Immune Cells Can Cause COPD, Study Finds

News

Exosomes — tiny vesicles used for cell communication, released from specific activated immune cells called polymorphonuclear leukocytes — can induce chronic obstructive pulmonary disease (COPD) when transferred to the lungs of ... Read more

January 15, 2019January 15, 2019

Verona Pharma’s Candidate RPL554 for COPD Will Be Named Ensifentrine

News

Verona Pharma’s investigational agent RPL554 will be named ensifentrine, the company announced. The “-fentrine” stem in the International Nonproprietary Names (INN) Programme indicates recognition from the World Health Organization (WHO) ... Read more

January 11, 2019January 11, 2019

ProAir Digihaler Approved for COPD and Asthma Patients to Digitally Track Their Albuterol Use

News

The ProAir Digihaler, a digital inhaler that allows patients with asthma and chronic obstructive pulmonary disease (COPD) to track their inhaler usage through a mobile app, has been approved ... Read more

January 8, 2019January 8, 2019

European Commission OKs Bevespi Aerosphere for Adults With COPD

News

Bevespi Aerosphere (glycopyrronium/formoterol fumarate), a therapy developed by AstraZeneca, has been approved by the European Commission as a maintenance treatment for adults with chronic obstructive pulmonary disease (COPD). Bevespi ... Read more

January 4, 2019January 4, 2019

Endobronchial Valve System Now Approved in US for Treatment of Severe Emphysema

News

The U.S. Food and Drug Administration has approved Olympus‘ Spiration Valve System (SVS) as a minimally invasive treatment for severe emphysema, a progressive form of chronic obstructive pulmonary disease (COPD). ... Read more

December 18, 2018December 18, 2018

Verona Pharma’s Phase 2 Trial Evaluating RPL554 for COPD Set to Begin

News

A Phase 2 clinical trial is enrolling participants to evaluate the safety and efficacy of Verona Pharma’s dry powder inhaler RPL554 as a potential maintenance treatment for people with moderate to ... Read more

December 11, 2018December 11, 2018

Obesity Strongly Linked to COPD in Individuals Who Never Smoked, Study Reports

News

Chronic obstructive pulmonary disease (COPD) is much more common in obese individuals ages 50 and older who have never smoked, according to a study that also shows that the ... Read more

December 4, 2018December 4, 2018

Few COPD Patients Enroll in Pulmonary Rehabilitation, Despite Benefits, Study Shows

News

Very few patients with chronic obstructive pulmonary disease (COPD) start pulmonary rehabilitation after being hospitalized, despite its proven benefits and clinical guidelines recommending it shortly after discharge, a study ... Read more

November 27, 2018November 27, 2018

Mucus Protects Lungs by Forming Layers, Preventing Worsening of Lung Diseases, Studies Reveal

News

Two new studies highlight the important role of mucus in cleaning and protecting the lungs, and how its accumulation and impaired clearance can contribute to the worsening of lung diseases ... Read more

Pin It on Pinterest